Rich Pharmaceuticals, Inc.
company.status.inactiveCIK 1504389fmd_0ST9XP31BGQB6T61DRZ6TE7W77Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Oct 01, 2010 to Mar 31, 2018, 29 periods
Latest annual · FY2018
Millions- Total revenues
- 0
- Gross profit
- (0)
- Operating income
- (1)
- Net income
- (2)
Latest quarter · Q4 FY2018
Millions- Total revenues
- 0
- Gross profit
- (0)
- Operating income
- (0)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2015 to FY2018
- n/m
- Revenue, 5 yearsFY2013 to FY2018
- n/m
- Net income, 5 yearsFY2013 to FY2018
- n/m
Rich Pharmaceuticals, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2018 | FY2017 | Change | Source |
|---|---|---|---|---|
| Revenue | $115,000 | 10-K 2018-07-17 · proof | ||
| Operating income | -$1.3 million | -$951,817 | 10-K 2018-07-17 · proof | |
| Net income | -$1.7 million | -$3.2 million | 10-K 2018-07-17 · proof | |
| Cash from operating activities | -$508,479 | -$553,394 | 10-K 2018-07-17 · proof | |
| Total assets | $37,429 | $53,028 | -29.4% | 10-K 2018-07-17 · proof |
| Total liabilities | $6.4 million | $5.4 million | +18.9% | 10-K 2018-07-17 · proof |
| Cash and cash equivalents | $6,222 | $40,903 | -84.8% | 10-K 2018-07-17 · proof |
- What was Rich Pharmaceuticals, Inc.'s revenue in fiscal 2018?
- Rich Pharmaceuticals, Inc. reported revenue of $115,000 for fiscal 2018 (the year ended Mar 31, 2018). Source: the 10-K filed with the SEC on Jul 17, 2018. SEC
- What was Rich Pharmaceuticals, Inc.'s operating income in fiscal 2018?
- Rich Pharmaceuticals, Inc. reported operating income of -$1.3 million for fiscal 2018 (the year ended Mar 31, 2018), against -$951,817 the year before. Source: the 10-K filed with the SEC on Jul 17, 2018. SEC
- What was Rich Pharmaceuticals, Inc.'s net income in fiscal 2018?
- Rich Pharmaceuticals, Inc. reported net income of -$1.7 million for fiscal 2018 (the year ended Mar 31, 2018), against -$3.2 million the year before. Source: the 10-K filed with the SEC on Jul 17, 2018. SEC
- What was Rich Pharmaceuticals, Inc.'s cash from operating activities in fiscal 2018?
- Rich Pharmaceuticals, Inc. reported cash from operating activities of -$508,479 for fiscal 2018 (the year ended Mar 31, 2018), against -$553,394 the year before. Source: the 10-K filed with the SEC on Jul 17, 2018. SEC
- What are Rich Pharmaceuticals, Inc.'s total assets?
- As of Mar 31, 2018, Rich Pharmaceuticals, Inc. reported total assets of $37,429, against $53,028 a year earlier (-29.4%). Source: the 10-K filed with the SEC on Jul 17, 2018. SEC
- What are Rich Pharmaceuticals, Inc.'s total liabilities?
- As of Mar 31, 2018, Rich Pharmaceuticals, Inc. reported total liabilities of $6.4 million, against $5.4 million a year earlier (+18.9%). Source: the 10-K filed with the SEC on Jul 17, 2018. SEC
- What are Rich Pharmaceuticals, Inc.'s cash and cash equivalents?
- As of Mar 31, 2018, Rich Pharmaceuticals, Inc. reported cash and cash equivalents of $6,222, against $40,903 a year earlier (-84.8%). Source: the 10-K filed with the SEC on Jul 17, 2018. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1504389&period_type=annual&limit=5"Information only, not investment advice.